Opioid Abuse Identification and Treatment: Matthew's Story
Estimated time to complete session: 75 mins.
Upon completion of this session, you should be able to:
1. Summarize the impact of the opioid epidemic of prescription opioids, illicit opioids (i.e., heroin, illicitly manufactured fentanyl, etc.).
2. Explain the DSM-5 criteria for opioid use disorder diagnosis.
3. Identify patients for whom naloxone coprescription and training is recommended.
4. Outline the options for medication-assisted treatment for patients with opioid dependence.
5. Describe the steps and requirements to obtain the waiver to enable treatment of patients with buprenorphine for opioid use disorder.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Tim Brown, PharmD, BCACP, FASHP – Director of Clinical Pharmacotherapy in Family Medicine, Center for Family Medicine at Akron General Medical Center, Cleveland Clinic Foundation Affiliate, Akron, Ohio
- 1.25 AAFP prescribed